the invention discloses chemical composition of phosphoric acid kitasamycin and a method for preparing the same.
本发明公开了磷酸吉他霉素的化学构成及制备方法。
objective:to evaluate the efficacy and adverse drug reactions of kitasamycin tartrateand erythromycin in treatment of mycoplasmal pneumonia.
目的:评价酒石酸吉他霉素和乳糖酸红霉素对支原体肺炎的疗效及药物的不良反应。
results:the ingredient and the biological potency of kitasamycin have positive correlation. when ingredient is in the zone(70.5~81.0), the result will be stable and near to the real potency.
so we measured the indexes of kitasamycin tartrate, such as effect of medicine, color degree, and selected an optimized salt-forming process and freeze-drying curve.
因此,通过测定成品酒石酸吉他霉素效价、色级等理化指标,对成盐工艺、冻干曲线进行优化选。
the phosphoric acid kitasamycin can be used as veterinary medicine, feed medicine additive, pre-mixing agent, and human medicine.
可用作兽药、饲料药物添加剂、预混剂,以及人用药品。
the prescription and preparation techniques of kitasamycin tablets were investigated for improvement of dissolution to meet the national standard.